Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen (Q44061486)

29 November 2017

title

Eudragit RS100 nanosuspensions for the ophthalmic controlled delivery of ibuprofen (English)

1 reference

29 November 2017

1 reference

29 November 2017

1 reference

29 November 2017

Piera Ferrara

1 reference

29 November 2017

Adriana Maltese

series ordinal

1 reference

29 November 2017

Antonina Puleo

series ordinal

1 reference

29 November 2017

Giovanni Puglisi

series ordinal

1 reference

29 November 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

European Journal of Pharmaceutical Sciences

29 November 2017

published in

1 reference

29 November 2017

1 reference

29 November 2017

issue

1-2

1 reference

29 November 2017

page(s)

53-61

1 reference

Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

The effect of treatment with topical nonsteroidal anti-inflammatory drugs with and without intraoperative epinephrine on the maintenance of mydriasis during cataract surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Physical and chemical factors influencing the release of drugs from acrylic resin films

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Preparation of controlled-release microspheres of ibuprofen with acrylic polymers by a novel quasi-emulsion solvent diffusion method

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Panoparticulate systems for improved drug delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Ophthalmic drug delivery systems--recent advances

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Ocular drug delivery of progesterone using nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Improvement of ocular penetration of amikacin sulphate by association to poly(butylcyanoacrylate) nanoparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Poly(epsilon-caprolactone) nanocapsules in carteolol ophthalmic delivery

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Effect of formulation variables on in vitro drug release and micromeritic properties of modified release ibuprofen microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

In vitro release kinetics of Tolmetin from tabletted Eudragit microparticles.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Preparation and analgesic activity of Eudragit RS100 microparticles containing diflunisal

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Flurbiprofen-loaded acrylate polymer nanosuspensions for ophthalmic application

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

The role of nonsteroidal antiinflammatory drugs in ocular inflammation.

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

Reduction of pupillary constriction during cataract surgery using suprofen

1 reference

https://api.crossref.org/works/10.1016%2FS0928-0987%2802%2900057-X

7 January 2021

10.1016/S0928-0987(02)00057-X

Identifiers

DOI

1 reference

29 November 2017

1 reference